Philadelphia, PANCT07927413Now EnrollingIRB Ready

Cerebrospinal Fluid (CSF) Leak Clinical Trial in Philadelphia, PA

Access cutting-edge cerebrospinal fluid (csf) leak treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by Corza Medical GmbH

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access cerebrospinal fluid (csf) leak specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cerebrospinal fluid (csf) leak treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this cerebrospinal fluid (csf) leak clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Cerebrospinal Fluid (CSF) Leak Study in Philadelphia

This retrospective observational cohort study compares the effectiveness and safety of adjunctive TachoSil® fibrin sealant patch with DuraSeal® hydrogel sealant for supporting dural sealing in adult patients undergoing cranial or spinal surgery at participating United States hospitals. Medical records will be reviewed to assess clinically evident cerebrospinal fluid leak or clinically evident pseudomeningocele within 90 days after surgery. The study will use 1:1 propensity score matching to evaluate whether TachoSil® is non-inferior to DuraSeal® and will assess additional effectiveness and safety outcomes.

Sponsor: Corza Medical GmbH

Who Can Participate

Inclusion Criteria

Aged ≥ 18 years
Had an inpatient encounter to select sites with a cranial or spinal neurological surgery that involves dural sealing performed and discharged during January 1, 2017, and March 31, 2026
Had use of TachoSil® or DuraSeal® sealants during the cranial or spinal neurological surgery as supportive dural sealing method Note: Any surgery meeting the above criteria is considered index surgery

Exclusion Criteria

Index surgery was trauma-related
Had an infection within 7 days prior to index date
Had any neurosurgery involving dural opening during the 12-month look-back period
Had neoplasm of dura mater/meningioma, requiring resection of dura during index visit (the earliest visit meeting selection criteria) or 12-month look-back period
Was pregnant at index visit
Had a CSF leak during the 12-month look-back period
If the surgical approach was transbasal or transpetrosal, if the arachnoid membrane and CSF- containing system remained intact, or if there was \>1 dura opening (excluding extra ventricular or lumbar drains) during index surgery
Had use of Evarrest patch, Tisseel, Adherus, CraniSeal, Duragen, fibrin glue or other dural sealing products during index surgery
Had radiation therapy to surgical field in the 3 months prior to index date
Had chronic corticosteroid use in the 3 months prior to index date
Had both TachoSil® and DuraSeal® used for dural closure during index neurological surgery

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT07927413) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cerebrospinal Fluid (CSF) Leak Treatment Options in Philadelphia, PA

If you're searching for cerebrospinal fluid (csf) leak treatment options in Philadelphia, PA, this clinical trial (NCT07927413) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cerebrospinal fluid (csf) leak specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cerebrospinal fluid (csf) leak clinical trials near you to find additional studies recruiting in your area.

More Follicular Lymphoma Trials in Philadelphia, PA

See all follicular lymphoma clinical trials recruiting in Philadelphia — not just this study.

Browse Follicular Lymphoma Trials in Philadelphia →

Browse More Trials by Condition

Follicular Lymphoma TrialsInfluenza TrialsAll Conditions →

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA